Company:  EYEPOINT PHARMACEUTICALS, ... (EYPT)
Form Type:  424B5
Filing Date:  11/18/2021 
CIK:  0001314102 
Address:  480 PLEASANT STREET
SUITE B300
 
City, State, Zip:  WATERTOWN, Massachusetts 02472 
Telephone:  617-926-5000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$6.43  
Change: 
-0.065 (-1.00%)  
Trade Time: 
02:20 PM EST  
Market Cap: 
$220.39M
Trade EYPT now with 

© 2023  
Description of Business
EyePoint Pharmaceuticals is a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology (Durasert) for sustained intraocular drug delivery including delivery of EYP-1901, an investigational sustained delivery intravitreal treatment currently in Phase 2 clinical trials. The proven Durasert drug delivery platform has been safely administered to thousands of patients' eyes across four U.S. FDA approved products, including YUTIQ® for the treatment of posterior segment uveitis, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts. Durasert allows for the development of a miniaturized solid cylinder of drug for sustained "zero-order kinetics" release delivered through a single intravitreal injection in the physician's office.
Register and access this filing in:     
  FORM 424B5
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS SUPPLEMENT
    THE OFFERING
    RISK FACTORS
    NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DILUTION
    DESCRIPTION OF PRE-FUNDED WARRANTS
    MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES
    UNDERWRITING
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    RISK FACTORS
    USE OF PROCEEDS
    PLAN OF DISTRIBUTION
    GENERAL DESCRIPTION OF OUR SECURITIES
    DESCRIPTION OF OUR COMMON STOCK
    Description of Certain Provisions of Delaware Law and our ...
    Transfer Agent and Registrar
    DESCRIPTION OF OUR PREFERRED STOCK
    DESCRIPTION OF OUR WARRANTS
    Description of Outstanding Warrants
    DESCRIPTION OF OUR DEBT SECURITIES
    DESCRIPTION OF OUR UNITS


EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.